These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 30979602)

  • 1. The effect of ticagrelor based dual antiplatelet therapy on development of late left ventricular thrombus after acute anterior ST elevation myocardial infarction.
    Altıntaş B; Altındağ R; Bilge Ö; Baysal E; Öztürk Ö; Yaylak B; Ede H; Karahan MZ; Burak C; Tanboğa İH
    Int J Cardiol; 2019 Jul; 287():19-26. PubMed ID: 30979602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis.
    Vercellino M; Sànchez FA; Boasi V; Perri D; Tacchi C; Secco GG; Cattunar S; Pistis G; Mascelli G
    BMC Cardiovasc Disord; 2017 Apr; 17(1):97. PubMed ID: 28381298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of oral P2Y12 inhibitors on residual thrombus burden and reperfusion indexes in patients with ST-segment elevation myocardial infarction.
    Di Vito L; Versaci F; Limbruno U; Pawlowski T; Gatto L; Romagnoli E; Cattabiani MA; Micari A; Trivisonno A; Marco V; Prati F
    J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):701-6. PubMed ID: 27467458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis.
    Bulluck H; Chan MHH; Paradies V; Yellon RL; Ho HH; Chan MY; Chin CWL; Tan JW; Hausenloy DJ
    J Cardiovasc Magn Reson; 2018 Nov; 20(1):72. PubMed ID: 30404623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of ticagrelor on microvascular perfusion in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Wang X; Li X; Wu H; Li R; Liu H; Wang L; Bai S; Zhang L; Chen T; Liu J; Li Q; Du R
    Coron Artery Dis; 2019 Aug; 30(5):317-322. PubMed ID: 30614823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Predictors of Left Ventricular Thrombus After Primary Percutaneous Coronary Intervention for Anterior ST-Segment Elevation Myocardial Infarction.
    Driesman A; Hyder O; Lang C; Stockwell P; Poppas A; Abbott JD
    Clin Cardiol; 2015 Oct; 38(10):590-7. PubMed ID: 26417910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk definition and outcomes with the application of the PEGASUS-TIMI 54 trial inclusion criteria to a "real world" STEMI population: results from the Italian "CARDIO-STEMI SANREMO" registry.
    Sanchez F; Boasi V; Vercellino M; Tacchi C; Cannarile P; Pingelli N; Perri D; Gomez L; Cattunar S; Mascelli G
    BMC Cardiovasc Disord; 2021 Mar; 21(1):144. PubMed ID: 33736607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Insights From a Single Institution Registry.
    Brener SJ; Alapati V; Benson MM; Chan D; Cunn G; Khan S; Kutkut I; Narayanan CA; O'Laughlin JP; Sacchi TJ
    J Invasive Cardiol; 2019 Aug; 31(8):235-238. PubMed ID: 31303603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
    Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM
    Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic warfarin post anterior ST-elevation myocardial infarction: A systematic review and meta-analysis.
    Moulson N; LaHaye SA; Bertrand OF; MacHaalany J
    Cardiovasc Revasc Med; 2017 Dec; 18(8):559-564. PubMed ID: 28501493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Ticagrelor on Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction (HEALING-AMI).
    Park Y; Koh JS; Lee JH; Park JH; Shin ES; Oh JH; Chun W; Lee SY; Bae JW; Kim JS; Kim W; Suh JW; Yang DH; Hong YJ; Chan MY; Kang MG; Park HW; Hwang SJ; Hwang JY; Ahn JH; Choi SW; Jeong YH;
    JACC Cardiovasc Interv; 2020 Oct; 13(19):2220-2234. PubMed ID: 33032710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and correlates of early left ventricular thrombus formation following anterior wall acute myocardial infarction treated with primary percutaneous coronary intervention.
    Shacham Y; Leshem-Rubinow E; Ben Assa E; Rogowski O; Topilsky Y; Roth A; Steinvil A
    Am J Cardiol; 2013 Mar; 111(5):667-70. PubMed ID: 23261006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity: The TOPIC-VASP Pre-Specified Analysis of the TOPIC Randomized Study.
    Deharo P; Quilici J; Camoin-Jau L; Johnson TW; Bassez C; Bonnet G; Fernandez M; Ibrahim M; Suchon P; Verdier V; Fourcade L; Morange PE; Bonnet JL; Alessi MC; Cuisset T
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2560-2570. PubMed ID: 29268886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based oral antiplatelet therapy among hospitalized Chinese patients with acute myocardial infarction: results from the Chinese acute myocardial infarction registry.
    Tang X; Liu L; Yang J; Gao Z; Zhao X; Qiao S; Gao R; Wang Z; Yuan J; Yang Y
    BMC Cardiovasc Disord; 2021 Jun; 21(1):299. PubMed ID: 34126921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy.
    Solheim S; Seljeflot I; Lunde K; Bjørnerheim R; Aakhus S; Forfang K; Arnesen H
    Am J Cardiol; 2010 Nov; 106(9):1197-200. PubMed ID: 21029812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Loading Doses With P2Y12-Receptor Antagonists in Patients Without Dual Antiplatelet Therapy Undergoing Elective Coronary Intervention.
    Piqueras-Flores J; Jurado-Román A; López-Lluva MT; Sánchez-Pérez I; Abellán-Huerta J; Lozano-Ruiz Poveda F
    J Cardiovasc Pharmacol; 2019 Jan; 73(1):56-59. PubMed ID: 30383607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term efficacy of ticagrelor in acute ST-segment elevation myocardial infarction patients undergoing an emergency percutaneous coronary intervention.
    Cao B; Qu F; Liu X; Gao C; Fu Q; Jiang C; Wei P; Ma Q
    Aging (Albany NY); 2019 Oct; 11(20):8925-8936. PubMed ID: 31665124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramyocardial dissecting hematoma in anterior wall ST elevation myocardial infarction: impact on left ventricular remodeling and prognosis.
    Spinelli L; Stabile E; Giugliano G; Morisco C; Giudice CA; Imbriaco M; Santoro M; Esposito G; Trimarco B
    Int J Cardiovasc Imaging; 2018 Feb; 34(2):201-210. PubMed ID: 28766162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy with ticagrelor for ST-elevated acute coronary syndrome accompanied by diabetes mellitus.
    Liu Y; Ding LY; Li XZ
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):312-318. PubMed ID: 31389599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of different antiplatelet therapies with mortality after primary percutaneous coronary intervention.
    Olier I; Sirker A; Hildick-Smith DJR; Kinnaird T; Ludman P; de Belder MA; Baumbach A; Byrne J; Rashid M; Curzen N; Mamas MA;
    Heart; 2018 Oct; 104(20):1683-1690. PubMed ID: 29437885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.